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Synthesis and characterization of polymers 
Gel permeation chromatography of polymers 
 
Figure S1. GPC elugram of polymer 13b. 
 
 
Figure S2. GPC elugram of polymerization of monomer 14a in  
diglyme (red) and THF (blue). 
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Figure S3. GPC elugram of protected (red) and unprotected (blue) polymer 14b. 
 
 
Bis-TEGylated poly(p-benzamide) (13a) 
 
 
Figure S4. Entire GPC elugram of polymer 13a, showing no peak at  
short elution time which would indicate aggregation (toluene at 23.8 min.). 
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Figure S5. 1H NMR spectrum (400 MHz) of polymer 13a in CDCl3,  
end group analysis indicates a polymer containing 25 repeat units (inset). 
 
 
 
Figure S6. 1H NMR spectra (300 MHz) of monomer 9a (green) and polymer 13a (blue) in CDCl3. 
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Figure S7. 13C NMR spectrum (100 MHz) of 13a in CDCl3. 
 
 
 
 
Figure S8. APT spectrum (100 MHz) of 13a in CDCl3. 
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N-protected, mono-TEGylated poly(p-benzamide) (14b) 
 
Figure S9. 1H NMR spectrum (300 MHz) of 14b in CDCl3. 
 
 
 
Figure S10. 13C NMR spectrum (75 MHz) of 14b in CDCl3. 
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Figure S11. MALDI-ToF mass spectrum of 14b. 
 
 
UV-vis measurements 
 
Figure S12. UV-vis measurement at 25°C of a chloroform solution (10 mg/mL) of polymer 13a 
before and after filtration. The solutions were diluted to c = 0.05 mg/mL before the measurement. 
Red: unfiltered, blue: filtered through a PTFE filter (0.2 µm).  
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DLS measurements 
 
Figure S13. Hydrodynamic radii of polymer 13a after 0h (red) and 12h (blue),  
calculated by the CONTIN method. 
 
 
Methyl-2,5-dihydroxy-4-nitrobenzoate (3) 
 
 
 
Figure S14. 1H NMR spectrum (300 MHz) of 3 in DMSO-d6. 
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Figure S15. 13C NMR spectrum (75 MHz) of 3 in DMSO-d6. 
 
 
 
 
 
Figure S16. APT spectrum (75 MHz) of 3 in DMSO-d6. 
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Figure S17. High resolution-mass spectrum of 3 (ESI-). 
 
 
 
 
Figure S18. RP-HPLC elugram of 3. 
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Methyl-2-hydroxy-4-nitrobenzoate (4) 
 
 
 
Figure S19. 1H NMR spectrum (300 MHz) of 4 in CDCl3. 
 
 
 
 
Figure S20. 13C NMR spectrum (75 MHz) of 4 in CDCl3. 
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Figure S21. APT spectrum (75 MHz) of 4 in CDCl3. 
 
 
 
 
Figure S22. High resolution-mass spectrum of 4 (ESI-). 
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Figure S23. RP-HPLC elugram of 4. 
 
 
 
 
Triethyleneglycol bromide (5) 
 
 
Figure S24. 1H NMR spectrum (300 MHz) of 5 in CDCl3. 
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Figure S25. 13C NMR spectrum (75 MHz) of 5 in CDCl3. 
 
 
Methyl-2,5-bis (2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-4-nitrobenzoate (6a) 


 
Figure S26. 1H NMR spectrum (360 MHz) of 6a in CDCl3 after purification  
via column chromatography. 
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
Figure S27. 13C NMR spectrum (90 MHz) of 6a in CDCl3 after purification  
via column chromatography. 
 
 


Figure S28. DEPT spectrum (90 MHz) of 6a in CDCl3 after purification  
via column chromatography. 
ht
tp
://
do
c.
re
ro
.c
h


Figure S29. High resolution-mass spectrum of 6a (ESI+) after purification  
via column chromatography. 
 
 

 
 Figure S30. RP-HPLC elugram of 6a after purification  
via column chromatography. 
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Methyl 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-4-nitrobenzoate (6b) 
 
Figure S31. 1H NMR spectrum (300 MHz) of 6b in CDCl3 after purification  
via column chromatography. 
 
 
 
Figure S32. 13C NMR spectrum (75 MHz) of 6b in CDCl3 after purification  
via column chromatography. 
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Figure S33. APT spectrum (75 MHz) of 6b in CDCl3 after purification  
via column chromatography. 
 
 
 
Figure S34. High resolution-mass spectrum of 6b (ESI+) after purification  
via column chromatography. 
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Figure S35. RP-HPLC elugram of 6b after purification  
via column chromatography. 
 
 
2,5-Bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-4-nitrobenzoic acid (7a) 
 
 
Figure S36. 1H NMR spectrum (360 MHz) of 7a in CDCl3. 
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Figure S37. 13C NMR spectrum (90 MHz) of 7a in CDCl3. 
 
 
 
Figure S38. DEPT spectrum (360 MHz) of 7a in CDCl3. 


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Figure S39. High resolution-mass spectrum of 7a (ESI+). 
. 
 
 
Figure S40. RP-HPLC elugram of 7a. 
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2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-4-nitrobenzoic acid (7b) 
 


Figure S41. 1H NMR spectrum (300 MHz) of 7b in CDCl3. 
 
 



Figure S42. 13C NMR spectrum (75 MHz) of 7b in CDCl3. 
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Figure S43. APT spectrum (75 MHz) of 7b in CDCl3. 
 



Figure S44. High resolution-mass spectrum of 7b (ESI+). 


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Figure S45. RP-HPLC elugram of 7b. 
 
 
Phenyl 2,5-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-4-nitrobenzoate (8a) 
 
 
 
Figure S46. 1H NMR spectrum (360 MHz) of 8a in CDCl3. 
 
 
ht
tp
://
do
c.
re
ro
.c
h
 
 
Figure S47. 13C NMR spectrum (90 MHz) of 8a in CDCl3. 
 
 
 
 
 
Figure S48. APT spectrum (90 MHz) of 8a in CDCl3. 
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Figure S49. High resolution-mass spectrum of 8a (ESI+). 
 


Figure S50. RP-HPLC elugram of crude 8a. 
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Phenyl 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-4-nitrobenzoate (8b) 
 
 
Figure S51. 1H NMR spectrum (300 MHz) of 8b in CDCl3. 
 
 
 
Figure S52. 13C NMR spectrum (75 MHz) of 8b in CDCl3. 
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Figure S53. APT NMR spectrum (75 MHz) of 8b in CDCl3. 
 
 

 
Figure S54. High resolution-mass spectrum of 8a (ESI+). 
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Figure S55. RP-HPLC elugram of crude 8b. 
 
 
Phenyl 4-amino-2,5-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzoate (9a) 
 


Figure S56. 1H NMR spectrum (300 MHz) of 9a in CDCl3 after purification via recycling HPLC. 
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Figure S57. 13C NMR spectrum (75 MHz) of 9a in CDCl3 after purification via recycling HPLC. 
 

 
Figure S58. DEPT spectrum (75 MHz) of 9a in CDCl3 after purification via recycling HPLC. 


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Figure S59. High resolution-mass spectrum of 9a (ESI+) after purification via recycling HPLC. 


 
Figure S60. RP-HPLC elugram of 9a after purification via recycling HPLC. 
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Phenyl 4-amino-2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzoate (9b) 
 
 
Figure S61. 1H NMR spectrum (300 MHz) of 9b in CDCl3  
after purification via column chromatography. 
 
 
 
Figure S62. 13C NMR spectrum (75 MHz) of 9b in CDCl3  
after purification via column chromatography. 
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Figure S63. APT spectrum (75 MHz) of 9b in CDCl3  
after purification via column chromatography. 
 
 


Figure S64. High resolution-mass spectrum of 9b (ESI+) after purification 
via column chromatography. 
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Figure S65. RP-HPLC of 9b after purification via column chromatography. 
 
 
Phenyl 4-((4-methoxybenzyl)amino)-2,5-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy) 
benzoate (10a) 
 
 
Figure S66. 1H NMR spectrum (300 MHz) of 10a in CDCl3 after purification via recycling HPLC. 
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Figure S67. 13C NMR spectrum (75 MHz) of 10a in CDCl3 after purification via recycling HPLC. 
 
 
 
Figure S68. APT spectrum (75 MHz) of 10a in CDCl3 after purification via recycling HPLC. 
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
Figure S69. High resolution-mass spectrum of 10a (ESI+) after purification via recycling HPLC. 



Figure S70. RP-HPLC elugram of 10a after purification via recycling HPLC. 
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 Phenyl 4-((4-methoxybenzyl)amino)-2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy) benzoate 
(10b) 


Figure S71. 1H NMR spectrum (300 MHz) of 10b in CDCl3 after purification via recycling HPLC. 


Figure S72. 13C NMR spectrum (75 MHz) of 10b in CDCl3 after purification via recycling HPLC. 
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Figure S73. APT spectrum (75 MHz) of 10a in CDCl3 after purification via recycling HPLC. 
 

 
Figure S74. High resolution-mass spectrum of 10b after purification via recycling HPLC. 


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Figure S75. RP-HPLC elugram of 10b after purification via recycling HPLC. 
 
 
 
 
 
 
4-Amino-2,5-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzoic acid (11) 


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
Figure S75. 1H NMR spectrum (360 MHz) of 11 in CDCl3. 
 


Figure S76. 13C NMR spectrum (90 MHz) of 11 in CDCl3. 


Figure S77. DEPT spectrum (90 MHz) of 11 in CDCl3. 
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Figure S78. High resolution-mass spectrum of 11 (ESI+). 



Figure S79. RP-HPLC elugram of 11. 
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